These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Congenital Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor: A Case Report and Review of the Literature. Jin SG; Jiang XP; Zhong L Pediatr Neonatol; 2016 Oct; 57(5):436-439. PubMed ID: 24480101 [TBL] [Abstract][Full Text] [Related]
30. FOXM1 is an oncogenic mediator in Ewing Sarcoma. Christensen L; Joo J; Lee S; Wai D; Triche TJ; May WA PLoS One; 2013; 8(1):e54556. PubMed ID: 23365673 [TBL] [Abstract][Full Text] [Related]
31. The evaluation of CD99 immunoreactivity and EWS/FLI1 translocation by fluorescence in situ hybridization in central PNETs and Ewing's sarcoma family of tumors. Vural C; Uluoğlu O; Akyürek N; Oğuz A; Karadeniz C Pathol Oncol Res; 2011 Sep; 17(3):619-25. PubMed ID: 21267687 [TBL] [Abstract][Full Text] [Related]
32. Primary uterine Ewing sarcoma - A case report. Wu YC; Kao YC; Chang CW Taiwan J Obstet Gynecol; 2021 Jan; 60(1):142-144. PubMed ID: 33494989 [TBL] [Abstract][Full Text] [Related]
33. Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor in the Adrenal Gland of a Child. Goudarzipour K; Farahmandi F; Mohammadi A; Taherian R Iran J Kidney Dis; 2018 May; 12(3):190-192. PubMed ID: 29891750 [TBL] [Abstract][Full Text] [Related]
34. Ewing sarcoma inhibition by disruption of EWSR1-FLI1 transcriptional activity and reactivation of p53. van der Ent W; Jochemsen AG; Teunisse AF; Krens SF; Szuhai K; Spaink HP; Hogendoorn PC; Snaar-Jagalska BE J Pathol; 2014 Aug; 233(4):415-24. PubMed ID: 24974828 [TBL] [Abstract][Full Text] [Related]
35. High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents, and young adults with primary metastatic Ewing sarcoma. Haveman LM; van Ewijk R; van Dalen EC; Breunis WB; Kremer LC; van den Berg H; Dirksen U; Merks JH Cochrane Database Syst Rev; 2021 Sep; 9(9):CD011405. PubMed ID: 34472082 [TBL] [Abstract][Full Text] [Related]
36. Combining PARP-1 inhibition and radiation in Ewing sarcoma results in lethal DNA damage. Lee HJ; Yoon C; Schmidt B; Park DJ; Zhang AY; Erkizan HV; Toretsky JA; Kirsch DG; Yoon SS Mol Cancer Ther; 2013 Nov; 12(11):2591-600. PubMed ID: 23966622 [TBL] [Abstract][Full Text] [Related]
37. Clinical and pathological features of primary neuroectodermal tumor/Ewing sarcoma of the kidney. Risi E; Iacovelli R; Altavilla A; Alesini D; Palazzo A; Mosillo C; Trenta P; Cortesi E Urology; 2013 Aug; 82(2):382-6. PubMed ID: 23800653 [TBL] [Abstract][Full Text] [Related]
38. Study of EWS/FLI-1 rearrangement in 18 cases of CK20+/CM2B4+ Merkel cell carcinoma using FISH and correlation to the differential diagnosis of Ewing sarcoma/peripheral neuroectodermal tumor. Fernandez-Flores A; Suarez-Peñaranda JM; Alonso S Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):379-85. PubMed ID: 23165331 [TBL] [Abstract][Full Text] [Related]
39. Molecular pathogenesis and targeted therapeutics in Ewing sarcoma/primitive neuroectodermal tumours. Kelleher FC; Thomas DM Clin Sarcoma Res; 2012 Feb; 2(1):6. PubMed ID: 22587874 [TBL] [Abstract][Full Text] [Related]
40. Characteristics of human Ewing/PNET sarcoma models. Teicher BA; Bagley RG; Rouleau C; Kruger A; Ren Y; Kurtzberg L Ann Saudi Med; 2011; 31(2):174-82. PubMed ID: 21422656 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]